New multifunctional AChE inhibitor drug prototypes protect against Aβ-induced memory deficit

[1]  Sarah M. Vaz,et al.  Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates. , 2018, European journal of medicinal chemistry.

[2]  Fan Li,et al.  Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease. , 2017, European journal of medicinal chemistry.

[3]  M. Mesulam,et al.  WITHDRAWN: Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research. , 2017, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  B. Jayaram,et al.  Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents. , 2017, European journal of medicinal chemistry.

[5]  A. Cavalli,et al.  Multitarget drug design strategy in Alzheimer's disease: focus on cholinergic transmission and amyloid-β aggregation. , 2017, Future medicinal chemistry.

[6]  T. Tüylü Küçükkılınç,et al.  Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles. , 2017, Bioorganic chemistry.

[7]  Irene Bolea,et al.  ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy , 2016, Front. Neurosci..

[8]  D. Yew,et al.  Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review. , 2016, Progress in histochemistry and cytochemistry.

[9]  Sage C. Arbor,et al.  Amyloid-beta Alzheimer targets — protein processing, lipid rafts, and amyloid-beta pores , 2016, The Yale journal of biology and medicine.

[10]  M. Hüll,et al.  Amyloid-β Load Predicts Medial Temporal Lobe Dysfunction in Alzheimer Dementia , 2013, The Journal of Nuclear Medicine.

[11]  Harald Hampel,et al.  Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research , 2018, The Journal of Prevention of Alzheimer's Disease.